CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes
RecruitingOBSERVATIONAL
Enrollment
160
Participants
Timeline
Start Date
October 4, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2026
Conditions
Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of OocytesAdvance Maternal AgeVitrification and Thawing
Trial Locations (1)
41009
RECRUITING
Vida Recoletas Sevilla S.L., Seville
All Listed Sponsors
collaborator
University of Seville, Spain
UNKNOWN
lead
Vida Recoletas Sevilla
OTHER
NCT06788379 - CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes | Biotech Hunter | Biotech Hunter